Sarah Blagden

Sarah Blagden is a Professor of Experimental Oncology at the University of Oxford. Her laboratory research is in investigating post-transcriptional mechanisms for ovarian cancer behavior. Her clinical research is in conducting early phase trials in novel cancer therapeutics for people with advanced malignancies.

Early life and education Sarah Blagden was born in Aldershot, Hampshire in 1969. Her father was Brigadier Patrick Blagden, a renowned mine clearance expert. She was educated in Haslemere in Surrey, and later received a BSc in pharmacology in 1991 and a medical degree (MBBS) at Charing Cross and Westminster Medical School, University of London in 1994.

In 2004, she received a PhD (as CRUK Clinical Fellow) in fruit fly genetics in the laboratory of Professor David Glover at Cambridge University. She serves on the Editorial Board of the British Journal of Cancer. In 2015, Blagden founded Prenostics a company dedicated to researching early cancer biomarkers.

Awards CRUK Junior Clinician Scientist PhD fellowship in 1999 at Cambridge University. CRUK clinical Fellow PhD in 2004 at Cambridge University. Fellowship of Royal College Physicians in 2010.